Page 1432 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

References 3

versus unfractionated heparin as anticoagulant during con- 76. Roberts PR, Black KW, Zaloga GP. Enteral feeding improves
tinuous venovenous hemodialysis with filtration. Crit Care Med. outcome and protects against glycerol-induced acute renal fail-
1999;27:2224-2228. ure in the rat. Am J Respir Crit Care Med. 1997;1156:1265-1269.
61. Joannidis M, Kountchev J, Rauchenzauner M, et al. Enoxaparin 77. Singer P. High-dose amino acid infusion preserves diuresis and
vs. unfractionated heparin for anticoagulation during con- improves nitrogen balance in non-oliguric acute renal failure.
tinuous veno-venous hemofiltration: a randomized controlled Wien Klin Wochenschr. 2007;119(7-8):218-222.
crossover study. Intensive Care Med. 2007;33(9):1571-1579. 78. Klein CJ, Moser-Veillon PB, Schweitzer A, et al. Magnesium,
62. Kern H, Ziemer S, Kox WJ. Bleeding after intermittent or calcium, zinc, and nitrogen loss in trauma patients dur-
continuous r-hirudin during CVVH. Intensive Care Med. ing continuous renal replacement. J Parenter Enteral Nutr.
1999;25:1311-1314. 2002;26:77-93.
63. Hursting MJ, Murray PT. Argatroban anticoagulation in 79. Nakamura AT, Btaiche IF, Pasko DA, Jain JC, Mueller BA. In
renal dysfunction: a literature analysis. Nephron Clin Pract. vitro clearance of trace elements via continuous renal replace-
2008;109:80-94. ment therapy. J Ren Nutr. 2004;14(4):214-219.
64. Reddy BV, Grossman EJ, Trevino SA, Hursting MJ, Murray PT. 80. Cano N, Fiaccadori E, Tesinsky P, et al. ESPEN Guidelines
Argatroban anticoagulation in patients with heparin-induced on enteral Nutrition: adult renal failure. Clin Nutr. 2006;
thrombocytopenia requiring renal replacement therapy. Ann 25(2):295-310.
Pharmacother. 2005;39:1601-1605. 81. Ganesan MV, Annigeri RA, Shankar B, et al. The protein equiv-
65. Link A, Girndt M, Selejan S, Mathes A, Bohm M, Rensing H. alent of nitrogen appearance in critically ill acute renal failure
Argatroban for anticoagulation in continuous renal replacment patients undergoing continuous renal replacement therapy.
therapy. Crit Care Med. 2009;37:105-110. J Ren Nutr. 2009;19(2):161-166.
66. Murray PT. Drug dosing in the intensive care unit: the critically 82. Scheinkestel CD, Kar L, Marshall K, et al. Prospective random-
ill are a special population too. Crit Care Med. 2009;37:342-343. ized trial to assess caloric and protein needs of critically ill,
67. Monchi M, Berghmans D, Ledoux D, et al. Citrate vs. heparin anuric, ventilated patients requiring renal replacement therapy.
for anticoagulation in continuous venovenous hemofiltration: Nutrition. 2003;19:909-916.
a prospective randomized trial. Intensive Care Med. 2004;30: 83. Bellomo R, Tan HK, Bonagiri S, et al. High protein intake dur-
260-265. ing continuous hemodiafiltration: impact on amino acids and
68. Kutsogiannis DJ, Gibney RTN, Stollery D, Gao J. Regional nitrogen balance. Int J Artif Organs. 2002;25(4):261-268.
citrate versus systemic heparin anticoagulation for continu- 84. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino
ous renal replacement in critically ill patients. Kidney Int. acid loss and nitrogen balance in critically ill children with
2005;67:2361-2367. acute renal failure: a prospective comparison between classic
69. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T. Is hemofiltration and hemofiltration with dialysis. Crit Care Med.
regional citrate superior to systemic heparin anticoagulation for 2000;28(4):1161-1165.
continuous renal replacement therapy? A prospective observa- 85. Pea F, Viale P. Bench-to-bedside review: appropriate antibiotic
tional study in an adult regional critical care system. J Crit Care. therapy in severe sepsis and septic shock, does the dose matter?
2005;20:155-161. Critical Care. 2009;13:214.
70. Hetzel GR, Taskaya G, Sucker C, et al. Citrate plasma levels in 86. Tam VH, Gamez EA, Weston JS, et al. Outcomes of bacteremia
patients under regional anticoagulation in continuous venove- due to Pseudomonas aeruginosa with reduced susceptibility to
nous hemofiltration. Am J Kidney Dis. 2006;48:806-811. piperacillin-tazobactam: implications on the appropriateness of
71. Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voot PHJ. the resistance breakpoint. Clin Infect Dis. 2008;46:862-867.
Detection of citrate overdose in critically ill patients on citrate- 87. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimi-
anticoagulated venovenous hemofiltration: use of ionized and crobial treatment of infections: a risk factor for hospital mortal-
total/ionized calcium. Clin Chem Lab Med. 2006;44(8) 962-966. ity among critically ill patients. Chest. 1999;115:462-474.
72. Rubinson L, Diette, GB, Song X, Brower RG, Krishnan JA. Low 88. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH.
caloric intake is associated with nosocomial bloodstream infec- Influence of inadequate antimicrobial treatment of bloodstream
tions in patients in the medical intensive care unit. Crit Care infections on patient outcomes in the ICU setting. Chest.
Med. 2004;32(2):350-357. 2000;118:146-155.
73. Barr J, Hecht M, Flavin KE, Khorana A, Gould MK. Outcomes 89. Valtonen M, Tiula E, Takkunen O, Backman JT, Neuvonen PJ.
in critically ill patients before and after the implementation of Elimination of piperacillin/tazobactam combination during
an evidence-based nutritional management protocol. Chest. continuous venovenous haemofiltration and haemodiafiltration
2004;125(4):1446-1457. in patients with acute renal failure. J Antimicrob Chemother.
74. Strack van Schijndel RJ, Weijs PJ, Koopmans RH, Sauerwein HP, 2001;48:881-884.
Beishuizen A, Girbes AR. Optimal nutrition during the period 90. Malone RS, Fish DN, Abraham E, Teitelbaum I. Pharmacokinetics
of mechanical ventilation decreases mortality in critically ill, of cefepime during continuous renal replacement therapy in
long-term female patients: a prospective observational cohort critically ill patients. Antimicrob Agents Chemother. 2001;45:
study. Crit Care. 2009;13(4):R132. 3148-3155.
75. Leblanc M, Garred LJ, Cardinal J, et al. Catabolism in critical ill- 91. Trotman RL, Williamson JC, Shoemaker M, Salzer WL.
ness: estimation from urea nitrogen appearance and creatinine Antibiotic dosing in critically ill adult patients receiving con-
production during continuous renal replacement therapy. Am J tinuous renal replacement therapy. Clin Infect Dis. 2005;41:
Kid Dis. 1998;32(3):444-453. 1159-1166.

Section08-O-Ref.indd 3 12/10/2014 6:08:08 PM